av/iol-chemicals-and-phar--big.svg

COM:IOLCP

IOL Chemicals and Pharmaceuticals Limited

  • Stock

Last Close

393.30

12/11 09:59

Market Cap

24.69B

Beta: -

Volume Today

66.56K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
5.64B
-
3.85B
31.73%
5.80B
50.86%
7.11B
22.44%
9.62B
35.39%
16.55B
72.01%
18.64B
12.60%
19.46B
4.43%
21.68B
11.42%
22.17B
2.25%
21.33B
3.80%
cost of revenue
3.70B
-
2.79B
24.52%
4.14B
48.12%
4.91B
18.67%
7.12B
44.96%
10.67B
49.95%
10.85B
1.66%
11.24B
3.64%
15.97B
42.03%
15.47B
3.10%
16.61B
7.36%
gross profit
1.94B
-
1.05B
45.50%
1.67B
58.12%
2.20B
31.77%
2.51B
14.02%
5.88B
134.65%
7.79B
32.44%
8.22B
5.54%
5.72B
30.45%
6.70B
17.20%
4.72B
29.57%
selling and marketing expenses
258.10M
-
466.10M
80.59%
484.50M
3.95%
507.80M
4.81%
668.40M
31.63%
618.50M
7.47%
general and administrative expenses
7.13M
-
9.31M
30.55%
10.10M
8.52%
14.60M
44.55%
24.40M
67.12%
40.50M
65.98%
45M
11.11%
58.30M
29.56%
selling general and administrative expenses
7.13M
-
9.31M
30.55%
268.20M
2,781.58%
480.70M
79.23%
508.90M
5.87%
548.30M
7.74%
713.40M
30.11%
676.80M
5.13%
3.04B
349.51%
research and development expenses
58.70M
-
67.60M
15.16%
74.70M
10.50%
111.40M
49.13%
167.50M
50.36%
other expenses
180K
-
180K
0%
180K
0%
180K
0%
1.29B
719,233.33%
7.40M
99.43%
14.80M
100%
12.70M
14.19%
33.10M
160.63%
256.10M
673.72%
cost and expenses
4.99B
-
4.02B
19.43%
5.59B
38.85%
6.39B
14.31%
8.68B
35.89%
12.78B
47.23%
13.25B
3.72%
13.93B
5.11%
19.52B
40.14%
20.38B
4.38%
19.65B
3.56%
operating expenses
1.29B
-
1.23B
4.89%
1.45B
17.81%
1.48B
1.87%
1.56B
5.77%
2.11B
34.86%
2.41B
14.16%
2.69B
11.72%
3.56B
32.25%
4.91B
37.97%
3.04B
37.98%
interest expense
540.90M
-
454.35M
16.00%
503.68M
10.86%
590M
17.14%
466.50M
20.93%
160.10M
65.68%
9.40M
94.13%
24.30M
158.51%
164.70M
577.78%
161M
2.25%
ebitda
957.39M
-
75.45M
92.12%
366.36M
385.57%
860.53M
134.89%
1.21B
40.68%
4.15B
243.03%
5.85B
40.87%
6.11B
4.50%
2.86B
53.29%
2.51B
12.00%
2.31B
8.23%
operating income
50.82M
-
-754.38M
1,584.33%
-385.50M
48.90%
54.77M
114.21%
908.50M
1,558.63%
3.77B
315.21%
5.38B
42.66%
5.53B
2.77%
2.16B
60.92%
1.80B
16.67%
1.68B
6.90%
depreciation and amortization
316.30M
-
289.11M
8.60%
296.86M
2.68%
299.47M
0.88%
302.10M
0.88%
322.90M
6.89%
357.30M
10.65%
389.20M
8.93%
432.60M
11.15%
461.60M
6.70%
629.10M
36.29%
total other income expenses net
-590.48M
-
-578.20M
2.08%
-603.13M
4.31%
-665.65M
10.37%
-595.50M
10.54%
-410.70M
31.03%
-49.20M
88.02%
183.20M
472.36%
87.30M
52.35%
85.50M
2.06%
139.70M
63.39%
income before tax
50.82M
-
-754.38M
1,584.33%
-385.50M
48.90%
54.77M
114.21%
313M
471.44%
3.36B
973.96%
5.33B
58.63%
5.71B
7.15%
2.25B
60.65%
1.89B
16.10%
1.82B
3.71%
income tax expense
17.83M
-
-87.87M
592.87%
14.76M
116.79%
12.50M
15.29%
36M
188.02%
994.50M
2,662.50%
1.72B
72.90%
1.27B
26.24%
571.80M
54.92%
495.10M
13.41%
472.20M
4.63%
net income
32.99M
-
-666.51M
2,120.08%
-400.26M
39.95%
42.28M
110.56%
277M
555.23%
2.37B
754.51%
3.61B
52.64%
4.45B
23.05%
1.68B
62.28%
1.39B
17.02%
1.34B
3.39%
weighted average shs out
27.22M
-
39.86M
46.43%
52.67M
32.11%
56.21M
6.72%
56.21M
0%
56.21M
0.01%
56.89M
1.21%
58.33M
2.54%
58.71M
0.64%
58.71M
0%
58.71M
0%
weighted average shs out dil
27.22M
-
40.07M
47.19%
52.67M
31.45%
56.21M
6.70%
56.21M
0%
56.21M
0.01%
57.01M
1.42%
58.33M
2.32%
58.71M
0.64%
58.71M
0%
58.71M
0%
eps
1.21
-
-16.72
1,481.82%
-7.60
54.55%
0.83
110.92%
4.93
493.98%
42.11
754.16%
63.51
50.82%
76.21
20.00%
28.56
62.52%
23.70
17.02%
22.90
3.38%
epsdiluted
1.21
-
-16.63
1,474.38%
-7.60
54.30%
0.83
110.92%
4.93
493.98%
42.11
754.16%
63.38
50.51%
76.21
20.24%
28.56
62.52%
23.70
17.02%
22.90
3.38%

All numbers in (except ratios and percentages)